Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Natural Vascular Scaffold (NVS) Therapy for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)

Next Previous
X
Search
Trial Profile

Natural Vascular Scaffold (NVS) Therapy for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA)

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 23 Oct 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Peripheral vascular disorder therapeutics Alucent Biomedical (Primary)
  • Indications Peripheral vascular disorders
  • Focus Therapeutic Use
  • Sponsors Alucent Biomedical

    • Most Recent Events

    • 13 Nov 2018 Status changed from active, no longer recruiting to completed.
    • 01 Mar 2018 According to an Alucent Biomedical company website, Alucent Medical changed its name to Alucent Biomedical.
    • 29 Nov 2017 Planned End Date changed from 3 Jun 2019 to 25 Jun 2018.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top